Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06252168

Registry of Acute Myocardial Infarction

Status
Recruiting
Phase
Study type
Observational
Enrollment
97,500 (estimated)
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers

Summary

The Registry of Acute Myocardial Infarction (RAMI) aims at regular and centralized acquiring and processing standard information about verified and suspected cases of acute myocardial infarction (AMI), monitoring of AMI cases, and establishing AMI diagnosis based on standard diagnostic criteria by doctors involved in the registry. The RAMI obtains data from all medical institutions, which could potentially document any cases of suspected AMI.

Detailed description

The study implements the methodology recommended by the World Health Organization (WHO) using unified diagnostic criteria (clinical, biochemical, electrocardiographic, and autopsy) for acute myocardial infarction (AMI). All primary information is recorded in a special primary registration card, which has been subject to updates in accordance with the requirements. All accumulated data is stored in RAMI analytic database. The database is designed and developed specifically for recording, accumulating, archiving, and statistical processing of collected data. It is equipped with a web user interface, a universal environment for generating consolidated distribution reporting, and the ability to import analytical data into expert analytical systems produced by other manufacturers. Data storage is implemented using the Oracle database management system. The information and analytical system of RAMI has passed the procedure of state registration of the database. Each reported case after the first 28 days from disease onset is assigned a specific diagnostic category (definite myocardial infarction, possible myocardial infarction, unconfirmed myocardial infarction, and insufficient data). At the end of each year of study, RAMI team calculates and analyzes the main epidemiological parameters, characterizing the disease distribution in the studied population (the city of Tomsk, Russian Federation) including morbidity, mortality, and lethality (general, in-hospital, and pre-hospital).

Conditions

Timeline

Start date
1984-01-01
Primary completion
2049-12-31
Completion
2050-12-31
First posted
2024-02-09
Last updated
2025-04-09

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT06252168. Inclusion in this directory is not an endorsement.